MedaSystems provides Clinical Request Management software for biopharma companies. MedaSystems' software platform streamlines the handling of requests for experimental therapies from healthcare providers. Their secure, GxP compliant application provides support for Expanded Access, Post-Trial Access and Investigator-Initiated Studies.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 10/12/23 | undisclosed | Seed |
Nina Capital Young Sohn | undisclosed |
| 01/09/24 | undisclosed | Venture |
Debiopharm | undisclosed |
